Leishmanicidal Metabolites from Cochliobolus sp.
Author Information
Author(s): Fernanda Fraga Campos, Luiz Henrique Rosa, Betania Barros Cota, Rachel Basques Caligiorne, Ana Lúcia Teles Rabello, Tânia Maria Almeida Alves, Carlos Augusto Rosa, Carlos Leomar Zani
Primary Institution: Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil
Hypothesis
Can metabolites from the endophytic fungus Cochliobolus sp. be effective against Leishmania parasites?
Conclusion
The study found that cochlioquinone A and isocochlioquinone A from Cochliobolus sp. effectively kill Leishmania amazonensis with selective toxicity.
Supporting Evidence
- The crude extract of Cochliobolus sp. killed 90% of Leishmania amazonensis.
- Cochlioquinone A and isocochlioquinone A showed EC50 values of 1.7 µM and 4.1 µM, respectively.
- Both compounds were inactive against three human cancer cell lines.
- The study highlights the potential of endophytic fungi as sources of new drug leads.
Takeaway
Researchers found that a fungus can make special chemicals that kill bad germs that cause leishmaniasis, which is a serious disease.
Methodology
The study involved isolating the fungus, extracting its metabolites, and testing their effects on Leishmania parasites and human cancer cell lines.
Limitations
The study did not explore the in vivo effects of the compounds or their long-term efficacy.
Statistical Information
Confidence Interval
1.5 to 1.9 µM for cochlioquinone A; 3.6 to 4.7 µM for isocochlioquinone A
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website